老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

158.14
-0.9900-0.62%
盘前：157.80-0.3400-0.21%05:24 EDT
成交量：43.28万
成交额：6,866.43万
市值：95.08亿
市盈率：-23.39
高：161.87
开：161.50
低：155.96
收：159.13
数据加载中...
总览公司新闻公告
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/10

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/05

关联方拟减持公告

144 - Report of proposed sale of securities
2023/04/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
更多